Centessa Pharmaceuticals plc — All Filings
558 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
144/A
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 | 0001470831-26-000331 | Mar 27, 2026 | Mar 26, 2026 |
| 4 | FORM 4 | 0001470831-26-000320 | Mar 26, 2026 | — |
| 144 | — | 0001969223-26-000400 | Mar 26, 2026 | — |
| 144 | — | 0001969223-26-000398 | Mar 26, 2026 | — |
| 4 | FORM 4 | 0001470831-26-000291 | Mar 18, 2026 | Mar 16, 2026 |
| 144 | — | 0001969223-26-000363 | Mar 17, 2026 | — |
| 4/A | FORM 4/A | 0001470831-26-000279 | Mar 16, 2026 | Mar 13, 2026 |
| 144 | — | 0001969223-26-000355 | Mar 16, 2026 | — |
| 4 | FORM 4 | 0001470831-26-000268 | Mar 13, 2026 | — |
| 4 | FORM 4 | 0001470831-26-000267 | Mar 13, 2026 | — |
| 144 | — | 0001969223-26-000348 | Mar 13, 2026 | — |
| 144 | — | 0001969223-26-000346 | Mar 13, 2026 | — |
| SCHEDULE 13G/A | — | 0000902664-26-001025 | Feb 17, 2026 | — |
| 8-K | 8-K | 0001193125-26-051424 | Feb 13, 2026 | Feb 9, 2026 |
| SCHEDULE 13G/A | — | 0000315066-26-000600 | Feb 6, 2026 | — |
| SCHEDULE 13G/A | — | 0000315066-26-000412 | Feb 5, 2026 | — |
| 4 | FORM 4 | 0001470831-26-000098 | Feb 3, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001470831-26-000096 | Feb 3, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001470831-26-000094 | Feb 3, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001470831-26-000092 | Feb 3, 2026 | Jan 30, 2026 |
| 4 | FORM 4 | 0001470831-26-000090 | Feb 3, 2026 | Feb 1, 2026 |
| 4 | FORM 4 | 0001470831-26-000088 | Feb 3, 2026 | Feb 1, 2026 |
| 4 | FORM 4 | 0001470831-26-000086 | Feb 3, 2026 | Feb 1, 2026 |
| 4 | FORM 4 | 0001470831-26-000084 | Feb 3, 2026 | Feb 1, 2026 |
| 144 | — | 0001969223-26-000076 | Jan 30, 2026 | — |
| 144 | — | 0001969223-26-000054 | Jan 21, 2026 | — |
| 8-K/A | 8-K/A | 0001193125-26-004896 | Jan 7, 2026 | Dec 5, 2025 |
| 144 | — | 0001969223-26-000012 | Jan 2, 2026 | — |
| 8-K | 8-K | 0001193125-25-315074 | Dec 11, 2025 | Dec 5, 2025 |
| 4 | FORM 4 | 0001470831-25-000390 | Dec 9, 2025 | — |
| 144 | — | 0001969223-25-001060 | Dec 9, 2025 | — |
| 4 | FORM 4 | 0001470831-25-000388 | Dec 8, 2025 | — |
| 144 | — | 0001969223-25-001049 | Dec 8, 2025 | — |
| SCHEDULE 13D/A | — | 0000950142-25-003091 | Nov 28, 2025 | — |
| 8-K | 8-K | 0001193125-25-292015 | Nov 24, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-292008 | Nov 24, 2025 | — |
| 4 | FORM 4 | 0001470831-25-000344 | Nov 18, 2025 | Nov 17, 2025 |
| 4 | FORM 4 | 0001470831-25-000343 | Nov 18, 2025 | Nov 17, 2025 |
| SCHEDULE 13D/A | — | 0000950142-25-003013 | Nov 17, 2025 | — |
| 144 | — | 0001969223-25-000958 | Nov 17, 2025 | — |
| 144 | — | 0001969223-25-000957 | Nov 17, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-004944 | Nov 14, 2025 | — |
| 4 | FORM 4 | 0001470831-25-000315 | Nov 13, 2025 | Nov 12, 2025 |
| SCHEDULE 13G/A | — | 0000902664-25-004889 | Nov 13, 2025 | — |
| 8-K | 8-K | 0001193125-25-278827 | Nov 13, 2025 | Nov 11, 2025 |
| 424B5 | 424B5 | 0001193125-25-278668 | Nov 13, 2025 | — |
| 144 | — | 0001969223-25-000941 | Nov 12, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-275608 | Nov 12, 2025 | — |
| SCHEDULE 13G | — | 0000315066-25-002724 | Nov 5, 2025 | — |
| 10-Q | 10-Q | 0001847903-25-000156 | Nov 5, 2025 | Sep 30, 2025 |